References
- Drummond M, Sculpher MJ, Torrance GW, O’Brein BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd Edition). Oxford University Press, NY, USA (2005).
- Klok RM, Brouwer WB, Annemans LJ, Bos JM, Postma MJ. Towards a healthier discount procedure. Expert Rev. Pharmacoecon. Outcomes Res. 5(1), 59–63 (2005).
- Parsonage M, Neuburger H. Discounting and health benefits. Health Econ. 1(1), 71–76 (1992).
- van Hout BA. Discounting costs and effects: a reconsideration. Health Econ. 7(7), 581–594 (1998).
- O’Mahony JF, de Kok IM, van Rosmalen J, Habbema JD, Brouwer W, van Ballegooijen M. Practical implications of differential discounting in cost–effectiveness analyses with varying numbers of cohorts. Value Health 14(4), 438–442 (2011).
- Westra TA, Parouty MB, Wilschut JC, Boersma C, Postma MJ. Practical implications of differential discounting of costs and health effects in cost–effectiveness analysis. Value Health 14(8), 1173–1174; author reply 1174 (2011).
- Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost–effectiveness analysis. Health Econ. 10(7), 587–599 (2001).
- Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ 331(7514), 446–448 (2005).
- Claxton K, Sculpher M, Culyer A et al. Discounting and cost–effectiveness in NICE – stepping back to sort out a confusion. Health Econ. 15(1), 1–4 (2006).
- Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 16(3), 307–317 (2007).
- Loewenstein GF, Prelec D. Anomalies in intertemporal choice: evidence and an interpretation. Quarterly J. Econ. 107, 573–597 (1992).
- Bazelon B, Smetters K. Discounting in the long term. Loyola Los Angeles Law Rev. 35(1), 277 (2002).
- Bos JM, Beutels P, Annemans L, Postma MJ. Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases. Pharmacoeconomics 22(18), 1171–1179 (2004).
- Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost–effectiveness in Health and Medicine. Oxford University Press, NY, USA (1996).
- Lipscomb J. Time preference for health in cost–effectiveness analysis. Med. Care 27(Suppl. 3), S233–S253 (1989).
- Ramsey FP. A mathematical theory of saving. Econ. J. 38, 543–559 (1928).
Websites
- International Society for Pharmacoeconomics and Outcomes Research. www.ispor.org
- National Institute for Health and Clinical Excellence. www.nice.org.uk
- UK Treasury: Economic Data. www.hm-treasury.gov.uk/green_book_guidance_discounting.htm